SCHUFA in 2019 und kostenlose Auskunft

Wir haben ein Zusammenfassung der SCHUFA News 2019 erstellt.
Ob aus Berlin, München, Franfurt oder Dortmund. Sie erhalten Auskunft kostenlos! Read More →

The post SCHUFA in 2019 und kostenlose Auskunft appeared first on Schufa Öffnungszeiten Berlin.



from Schufa Öffnungszeiten Berlin http://bit.ly/2rVbQQq
via IFTTT
Share:

jobvector career day in München

jobvector career day in München


image description
Die Karrieremesse jobvector career day findet am 19. Februar 2019 wieder in München statt. Das Recruiting-Event richtet sich an Absolventen und Berufserfahrene aus Technik, IT, Medizin & Naturwissenschaft. AufBewerber warten neben Jobs bei Top-Arbeitgebern hilfreiche Informationen zu Beruf und Karri...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Congressional report: Drug companies, DEA, failed to stop flow of millions of opioid pills

Congressional report: Drug companies, DEA, failed to stop flow of millions of opioid pills


The distributors of powerful prescription opioids and the Drug Enforcement Administration failed to stop the flow of millions of pills into rural West Virginia despite rampant warning signs that the pills were being diverted for abuse, inertia that contributed to the nation's opioid epidemic, a congressional report has found. A report from the majority staff of the House Energy and Commerce Committee found that distributors, which fulfill orders for prescription drugs to pharmacies, failed to conduct proper oversight of their customers by not questioning suspicious activity and not properly monitoring the quantity of painkillers that were being shipped to individual pharmacies.



from Biotech News
Share:

Lilly, Aduro Biotech in Immunotherapy Alliance

Lilly, Aduro Biotech in Immunotherapy Alliance


Eli Lilly and Co. and Aduro Biotech, Inc. have entered a research collaboration and exclusive license agreement for Aduro's cGAS-STING Pathway Inhibitor program for the development of novel immunotherapies for autoimmune and other inflammatory diseases.



from Biotech News
Share:

J&J Loses Bid to Have $4.7B Talc Verdict Set Aside, Vows Appeal

J&J Loses Bid to Have $4.7B Talc Verdict Set Aside, Vows Appeal


Johnson & Johnson failed to persuade a Missouri trial judge to set aside a verdict awarding a record $4.69 billion to 22 women who blamed their ovarian cancer on asbestos in the company's Baby Powder and other talc products. According to court records, Judge Rex Burlison on Wednesday denied the company's request, but a detailed opinion of the ruling was not immediately available.



from Biotech News
Share:

US stocks rise before Federal Reserve meeting; oil rebounds

US stocks rise before Federal Reserve meeting; oil rebounds


U.S. stocks are climbing Wednesday morning as a modest recovery in oil prices pulls energy companies slightly higher following huge losses a day earlier. Markets were relatively quiet as the Federal Reserve wraps up its last meeting of the year.



from Biotech News
Share:

GSK, Pfizer to merge health care divisions

GSK, Pfizer to merge health care divisions


This April 20, 2009 file photo, shows the British pharmaceuticals firm GlaxoSmithKline in London. Drugmakers GlaxoSmithKline and Pfizer are merging their healthcare divisions, creating a business with combined sales of 9.8 billion pounds .



from Biotech News
Share:

UPDATE 2-J&J says Indian drug regulators visited facilities, took talc samples

UPDATE 2-J&J says Indian drug regulators visited facilities, took talc samples


FILE PHOTO: Bottles of Johnson & Johnson baby powder line a drugstore shelf in New York October 15, 2015. REUTERS/Lucas Jackson/File Photo The visits came as regulators in India launched an investigation into J&J's Baby Powder following a Reuters report last Friday that the firm knew for decades that cancer-causing asbestos could be found in the product.



from Biotech News
Share:

GlaxoSmithKline agrees consumer tie-up with Pfizer ahead of future spin-off

GlaxoSmithKline agrees consumer tie-up with Pfizer ahead of future spin-off


British drugs giant GlaxoSmithKline has agreed a tie-up with US rival Pfizer to merge their consumer healthcare divisions to create a business with combined sales of 9.8 billion. The deal paves the way for Glaxo to break itself up to form two separate UK-based companies one focused on pharmaceuticals and vaccines, and the other on consumer healthcare.



from Biotech News
Share:

Switch-in-a-cell electrifies life

Switch-in-a-cell electrifies life


Rice University scientists used E. coli bacteria as a platform to test protein switches that can be used to control the flow of electrons. Proteins placed in cells can simply be turned on and off with chemical signals.



from Biotech News
Share:

Nutritionist recommends these dishes to help you fight off a cold or the flu

Nutritionist recommends these dishes to help you fight off a cold or the flu


Every year Americans suffer from about a 1 billion colds and up to 20 percent of them get the flu, according to the Centers for Disease Control and Prevention . Fox News' Dr. Manny Alvarez sits down with nutritionist Frances Largeman-Roth to go over the best foods and dishes that can help fight off that nasty cold or flu this year.



from Biotech News
Share:

GlaxoSmithKline und Pfizer legen Consumer-Health-Sparten zusammen

GlaxoSmithKline und Pfizer legen Consumer-Health-Sparten zusammen


(dpa-AFX) Der britische Pharmakonzern GlaxoSmithKline (GSK) und der US-Pharmariese Pfizer bündeln ihre Geschäfte mit rezeptfreien Mitteln. Beide Konzerne werden ihre jeweiligen Consumer-Healthcare-Sparten (auch Selbstmedikation genannt) in ein Gemeinschaftsunternehmen einbringen, wie GlaxoSmithKline...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

New Hampshire physician assistant guilty of Insys opioid kickback scheme

New Hampshire physician assistant guilty of Insys opioid kickback scheme


A former physician assistant in New Hampshire was convicted on Tuesday of charges that he accepted nearly US$50,000 in kickbacks from Insys Therapeutics Inc in exchange for prescribing its addictive fentanyl spray. FILE PHOTO: Christopher Clough, a former physician assistant, arrives at the federal courthouse in Concord, New Hampshire, U.S., December 12, 2018.



from Biotech News
Share:

Eli Lilly And Co (LLY) Shares Sold by Her Majesty the Queen in Right...

Eli Lilly And Co (LLY) Shares Sold by Her Majesty the Queen in Right...


Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp reduced its stake in Eli Lilly And Co by 30.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 236,100 shares of the company's stock after selling 101,600 shares during the period.



from Biotech News
Share:

Hawlik Group übernimmt Dronania pharmaceuticals

Hawlik Group übernimmt Dronania pharmaceuticals


Mit dem Erwerb des Lohnherstellers Dronania pharmaceuticals GmbH erlangt die Hawlik Group (Hawlik Holding GmbH) die Möglichkeit, pflanzliche Arzneimittel herzustellen und kann wichtige Marktanteile als Lohnhersteller ausbauen. Zum 02.01.2019 wird die Dronania pharmaceuticals GmbH in die Hawlik Group...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Von der Idee zum Geschäftsmodell

Von der Idee zum Geschäftsmodell


image description
Start-ups können sich bis zum 18. Januar 2019 für die Konzeptphase des Science4Life Venture Cup bewerben und ihre Idee zu einem Geschäftskonzept weiterentwickeln. Das Konzept wird online zusammen mit einer ersten Markteinschätzung und Kurzvorstellung des Gründerteams eingereicht. Science4Life lädt d...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Royal London Asset Management Ltd. Acquires Shares of 1,240,786 Johnson & Johnson

Royal London Asset Management Ltd. Acquires Shares of 1,240,786 Johnson & Johnson


Royal London Asset Management Ltd. acquired a new position in Johnson & Johnson in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission . The fund acquired 1,240,786 shares of the company's stock, valued at approximately $150,576,000.



from Biotech News
Share:

Acticor Biotech Appoints Dr Andrea Comenducci as Medical Director

Acticor Biotech Appoints Dr Andrea Comenducci as Medical Director


Dec 18, 2018--Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombo-embolic diseases, including stroke and pulmonary embolism, today announced the appointment of Dr Andrea Comenducci MD as Medical Director in charge of clinical R&D and medical affairs. Dr Comenducci specialises in the cardiovascular field, and his priority will be to lead, with the support of a strengthened clinical team, the current Phase II clinical trial of ACT017, Acticor Biotech's flagship product for acute ischemic stroke.



from Biotech News
Share:

Recent Investment Analysts' Ratings Updates for Bristol-Myers Squibb

Recent Investment Analysts' Ratings Updates for Bristol-Myers Squibb


A number of firms have modified their ratings and price targets on shares of Bristol-Myers Squibb recently: 12/13/2018 - Bristol-Myers Squibb had its "hold" rating reaffirmed by analysts at Credit Suisse Group AG. They now have a $59.00 price target on the stock.



from Biotech News
Share:

J&J announces $5 billion share buyback after shares extend losses

J&J announces $5 billion share buyback after shares extend losses


Johnson & Johnson said on Monday it plans to buy back up to $5 billion of its stock, after a Reuters report on Friday that the company knew for decades that its Baby Powder contained cancer-causing asbestos wiped about $40 billion from its market value. Shares of the company closed down 3 percent on Monday, extending a 10 percent fall on Friday after the report was published.



from Biotech News
Share:

Laurel Wealth Advisors Inc. Sells 1,380 Shares of SPDR S&P Biotech Etf

Laurel Wealth Advisors Inc. Sells 1,380 Shares of SPDR S&P Biotech Etf


Laurel Wealth Advisors Inc. trimmed its stake in SPDR S&P Biotech ETF by 7.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 16,730 shares of the exchange traded fund's stock after selling 1,380 shares during the quarter.



from Biotech News
Share:

America's favorite regional fast food chains: Which restaurant ranked No. 1?

America's favorite regional fast food chains: Which restaurant ranked No. 1?


Americans love fast food. So much so that around 40 percent of us consume it every day, according to the Centers for Disease Control and Prevention.



from Biotech News
Share:

Vaping spikes among teens

Vaping spikes among teens


Vaping liquid available at Twilight Vapor, in Danbury, Conn. Use of vaping devices among many teens has spiked about 10 percent in the past year, according to the National Institutes of Health.



from Biotech News
Share:

US stocks close at 14-month low in broad sell-off

US stocks close at 14-month low in broad sell-off


US equity indexes slid to their lowest close in 14 months as investors weighed the impact of the Federal Reserve on growth in an economy already anxious over trade, geopolitical tensions and a possible government shutdown. The S&P 500 Index finished Monday's session its lowest level since October 2017.



from Biotech News
Share:

Versant Ventures Raises USD100 Million Canadian Fund

Versant Ventures Raises USD100 Million Canadian Fund


TORONTO & VANCOUVER, British Columbia & MONTREAL-- --Dec 17, 2018--Versant Ventures today announced that it raised USD100 million for a Canadian fund called Versant Voyageurs I. Voyageurs will be deployed across five to eight startup companies with Canadian operations. The fund will be invested side by side with Versant's primary biotech funds, including today's newly announced USD600 million Versant Venture Capital VII.



from Biotech News
Share:

Interest in Johnson & Johnson Stock Dries Up Amid Baby Powder Scandal

Interest in Johnson & Johnson Stock Dries Up Amid Baby Powder Scandal


The market appears to still be spooked by JNJ as shares are set to open at their lowest level since July amid the Reuters articles fallout. Johnson & Johnson shares continue to plunge on Monday morning as the market continues to deal with with the risks stemming from the company's recent scandal related to asbestos in their baby powder products.



from Biotech News
Share:

Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trial

Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trial


Eli Lilly and Co said on Monday its psoriatic arthritis drug, Taltz, was found to be more effective than the world's best-selling prescription medicine, AbbVie Inc's Humira, in a late-stage trial. FILE PHOTO: The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg, France, February 1, 2018.



from Biotech News
Share:

McCracken senior strives to keep positive mindset

McCracken senior strives to keep positive mindset


We have used your information to see if you have a subscription with us, but did not find one.



from Biotech News
Share:

Taisho said to near US$1.6 billion deal for Bristol-Myers's UPSA: Bloomberg

Taisho said to near US$1.6 billion deal for Bristol-Myers's UPSA: Bloomberg


Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd is said to be close to a US$1.6 billion deal for Bristol-Myers Squibb Co's French over-the-counter drugs business UPSA, Bloomberg reported on Sunday, citing sources familiar with the matter. Employees work on paracetamol production line for UPSA brand of Bristol-Myers Squibb Group at the company's factory in Le Passage, near Agen, France March 29, 2018.



from Biotech News
Share:

Traders Buy Biogen (BIIB) on Weakness

Traders Buy Biogen (BIIB) on Weakness


Investors bought shares of Biogen Inc on weakness during trading on Friday. $136.37 million flowed into the stock on the tick-up and $76.70 million flowed out of the stock on the tick-down, for a money net flow of $59.67 million into the stock.



from Biotech News
Share:

Meridian Bioscience, Inc. (VIVO) Stake Lifted by Renaissance Technologies LLC

Meridian Bioscience, Inc. (VIVO) Stake Lifted by Renaissance Technologies LLC


Renaissance Technologies LLC lifted its holdings in shares of Meridian Bioscience, Inc. by 6.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,801,208 shares of the company's stock after purchasing an additional 169,932 shares during the quarter.



from Biotech News
Share:

Trinity Biotech (TRIB) Reaches New 1-Year Low at $2.57

Trinity Biotech (TRIB) Reaches New 1-Year Low at $2.57


Trinity Biotech plc 's share price reached a new 52-week low on Friday . The company traded as low as $2.57 and last traded at $2.59, with a volume of 64157 shares.



from Biotech News
Share:

Hessen dominiert Gehaltsranking für Führungskräfte

Hessen dominiert Gehaltsranking für Führungskräfte


image description
Laut einer aktuellen Auswertung von Gehalt.de verdienen Führungskräfte in Hessen das höchste Gehalt. Sie erhalten demnach ein Jahreseinkommen in Höhe von 101.629 Euro. Auf dem zweiten Rang liegen leitende Beschäftigte in Bayern mit 97.850 Euro. Es folge nauf dem dritten Platz Führungskräfte aus Bade...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

National Pension Service Has $27 Million Holdings in IDEXX Laboratories, Inc.

National Pension Service Has $27 Million Holdings in IDEXX Laboratories, Inc.


National Pension Service boosted its stake in shares of IDEXX Laboratories, Inc. by 19.0% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 108,146 shares of the company's stock after purchasing an additional 17,284 shares during the period.



from Biotech News
Share:

Cumberland Partners Ltd Has $1.24 Million Holdings in Amgen, Inc.

Cumberland Partners Ltd Has $1.24 Million Holdings in Amgen, Inc.


Cumberland Partners Ltd grew its position in shares of Amgen, Inc. by 24.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission . The fund owned 5,999 shares of the medical research company's stock after purchasing an additional 1,175 shares during the period.



from Biotech News
Share:

USANA Health Sciences (USNA) & China Jo-Jo Drugstores (CJJD) Head to Head Analysis

USANA Health Sciences (USNA) & China Jo-Jo Drugstores (CJJD) Head to Head Analysis


USANA Health Sciences and China Jo-Jo Drugstores are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations. This table compares USANA Health Sciences and China Jo-Jo Drugstores' top-line revenue, earnings per share and valuation.



from Biotech News
Share:

Avanos Medical (AVNS) and RTI Surgical (RTIX) Head to Head Contrast

Avanos Medical (AVNS) and RTI Surgical (RTIX) Head to Head Contrast


Avanos Medical and RTI Surgical are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation. Avanos Medical has a beta of 1.8, suggesting that its share price is 80% more volatile than the S&P 500.



from Biotech News
Share:

Fortress Biotech (FBIO) SVP George Avgerinos Sells 97,325 Shares of Stock

Fortress Biotech (FBIO) SVP George Avgerinos Sells 97,325 Shares of Stock


Fortress Biotech SVP George Avgerinos sold 97,325 shares of the stock in a transaction on Tuesday, December 11th. The shares were sold at an average price of $1.05, for a total value of $102,191.25.



from Biotech News
Share:

Cash-strapped public health services toil to fight poliolike illness hitting kids

Cash-strapped public health services toil to fight poliolike illness hitting kids


Dr. Keith Van Haren, a neurologist at Stanford University Medical Center and a CDC medical adviser, complained to CNN in November about the CDC's slow reaction to AFM. "Frustrated and disappointed -- I think that's exactly how most of us feel."



from Biotech News
Share:

Merck to acquire privately held Antelliq Group

Merck to acquire privately held Antelliq Group


Merck and privately held Antelliq Group announced Dec. 14 that they have signed a definitive agreement under which Merck will acquire Antelliq for approximately 2.1 billion euros . Antelliq will be a wholly owned and separately operated subsidiary within the Merck Animal Health division.



from Biotech News
Share:

University of Illinois professor fired for falsifying data in grant applications

University of Illinois professor fired for falsifying data in grant applications


Fei Wang, an associate professor of cell and developmental biology at the University of Illinois at Urbana-Champaign was fired after board members determined that he fabricated and falsified scientific data in grant applications. A tenured biology professor at the University of Illinois at Urbana-Champaign was fired Friday, a rare punishment that essentially means a career death sentence in higher education and that has happened only once before at the state's flagship public university.



from Biotech News
Share:

Seth Klarman Gains Stake In Akebia Therapeutics

Seth Klarman Gains Stake In Akebia Therapeutics


Klarman's Baupost portfolio contained 25,791,678 shares of Keryx at third-quarter end, equating to a 21.4% stake in the company. The value investor bought the position over 2014 and the first half of 2015 at lofty prices averaging around $10 to the mid-teens.



from Biotech News
Share:

USANA Health Sciences, Inc. (USNA) Director Feng Peng Sells 282 Shares

USANA Health Sciences, Inc. (USNA) Director Feng Peng Sells 282 Shares


USANA Health Sciences, Inc. Director Feng Peng sold 282 shares of the business's stock in a transaction that occurred on Wednesday, December 12th. The stock was sold at an average price of $124.71, for a total value of $35,168.22.



from Biotech News
Share:

Stocks plunge to 8-month lows on growth fears; J&J nosedives

Stocks plunge to 8-month lows on growth fears; J&J nosedives


In this Nov. 29, 2018, file photo trader Timothy Nick works on the floor of the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EST on Friday, Dec. 14. FILE- In this Nov. 29, 2018, file photo trader Timothy Nick works on the floor of the New York Stock Exchange.



from Biotech News
Share:

Johnson & Johnson knew for decades that asbestos lurked in its Baby Powder

Johnson & Johnson knew for decades that asbestos lurked in its Baby Powder


FILE PHOTO: A bottle of Johnson and Johnson Baby Powder is seen in a photo illustration taken in New York, February 24, 2016. REUTERS/Mike Segar/Illustration She knew that her cancer, mesothelioma, arose in the delicate membrane surrounding her lungs and other organs.



from Biotech News
Share:

US stocks stumble again; Johnson & Johnson nosedives

US stocks stumble again; Johnson & Johnson nosedives


Stocks are sagging Friday after weak economic data from China has investors worrying about the global economy again.



from Biotech News
Share:

Romaine lettuce E. coli outbreak traced to California farm, CDC reports

Romaine lettuce E. coli outbreak traced to California farm, CDC reports


The Centers for Disease Control and Prevention said on Thursday that the E. coli strain was found in an irrigation reservoir on a property owned by Adam Brothers Family Farms in Santa Barbara County, CA. "We cannot say how many cases are linked to this specific farm at this time," Ian Williams, chief of the CDC's outbreak response and prevention branch, said at a press briefing.



from Biotech News
Share:

UPDATE 2-Thyssenkrupp fills key management posts after year of turmoil

UPDATE 2-Thyssenkrupp fills key management posts after year of turmoil


FILE PHOTO: Johannes Dietsch, CFO of German drugmaker Bayer AG, is listening to journalists' questions during the annual results news conference in Leverkusen, Germany February 22, 2017. REUTERS/Wolfgang Rattay Dietsch, 56, joins Thyssenkrupp during one of its largest ever restructurings: a planned spin-off of its elevators, car parts and plant engineering units into a separately listed entity to be called Thyssenkrupp Industrials.



from Biotech News
Share:

Nature's Sunshine Products (NATR) Major Shareholder Wynnefield...

Nature's Sunshine Products (NATR) Major Shareholder Wynnefield...


Nature's Sunshine Products major shareholder Wynnefield Partners Small Cap purchased 2,516 shares of the stock in a transaction on Wednesday, December 12th. The stock was acquired at an average cost of $8.84 per share, with a total value of $22,241.44.



from Biotech News
Share:

WealthPLAN Partners LLC Buys 5,574 Shares of Johnson & Johnson

WealthPLAN Partners LLC Buys 5,574 Shares of Johnson & Johnson


WealthPLAN Partners LLC grew its stake in shares of Johnson & Johnson by 17.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission . The institutional investor owned 37,529 shares of the company's stock after acquiring an additional 5,574 shares during the period.



from Biotech News
Share:

Mylan wins patent dispute with Sanofi over insulin product

Mylan wins patent dispute with Sanofi over insulin product


Sanofi sells the product in vials and as a disposable injection. Mylan currently has a new drug application pending review for generic versions of Lantus.



from Biotech News
Share:

Aggressive Response Limits Food Poisoning in the U.S.

Aggressive Response Limits Food Poisoning in the U.S.


The reason the risk of infection is so small is because the Centers for Disease Control and Prevention tracks the infection down so quickly. Regarding Jim Prevor's "Lettuce Try Not to Panic" : Thank goodness the risk of being infected by E. coli 0157:H7 is very small when the U.S. population is the sample size.



from Biotech News
Share:

Gun deaths in US reach highest level in nearly 40 years, CDC data reveal

Gun deaths in US reach highest level in nearly 40 years, CDC data reveal


Thank you for reading 5 free articles on martinsvillebulletin.com . You can come back at the end of your 30-day period for another 5 free articles, or you can purchase a subscription and continue to enjoy valuable local news and information.



from Biotech News
Share:

MannKind Co. (MNKD) Forecasted to Post FY2018 Earnings of ($0.71) Per Share

MannKind Co. (MNKD) Forecasted to Post FY2018 Earnings of ($0.71) Per Share


Investment analysts at Zacks Investment Research issued their FY2018 earnings estimates for MannKind in a research report issued on Monday, December 10th. Zacks Investment Research analyst B. Marckx expects that the biopharmaceutical company will earn per share for the year.



from Biotech News
Share:

c-LEcta: Successful Transformation into a Product Company in 2018 with a Promising Outlook for 2019

c-LEcta: Successful Transformation into a Product Company in 2018 with a Promising Outlook for 2019


Dec 13, 2018--c-LEcta, a globally active biotechnology company with technology leadership in enzyme engineering and bioprocess development for regulated markets such as the food and pharmaceutical industries, continued its successful development towards becoming a product company in fiscal year 2018. Successful products marketed by c-LEcta itself such as DENARASEA contributed to this development.



from Biotech News
Share:

Officer suffers minor injuries in collision in La Jolla

Officer suffers minor injuries in collision in La Jolla


The collision was reported about 7:20 p.m. at the intersection of Draper Avenue and Pearl Street, according to the San Diego Police Department. It was unclear if anyone in the other vehicle was injured or if the cruiser was responding to a call with its emergency lights and siren at the time of the crash.



from Biotech News
Share:

Baton Rouge partners with federal officials for 'unprecedented' collection of medical data

Baton Rouge partners with federal officials for 'unprecedented' collection of medical data


Dr. Vindell Washington, at podium, announces a partnership between Baton Rouge and the National Institutes of Health for the agency's All of Us research program. The initiative seeks to collect health data from 1 million people and track it over a decade.



from Biotech News
Share:

Eli Lilly And Co (LLY) Shares Bought by Verition Fund Management LLC

Eli Lilly And Co (LLY) Shares Bought by Verition Fund Management LLC


Verition Fund Management LLC grew its position in shares of Eli Lilly And Co by 967.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 115,029 shares of the company's stock after purchasing an additional 104,256 shares during the quarter.



from Biotech News
Share:

Lilly partners with AC Immune for Alzheimer's treatment

Lilly partners with AC Immune for Alzheimer's treatment


REUTERS: U.S. drugmaker Eli Lilly & Co and AC Immune SA have agreed to jointly develop the Swiss biotech's potential treatment for Alzheimer's disease. There is a desperate need for a treatment for Alzheimer's disease.



from Biotech News
Share:

EU-Gericht hebt Kartellstrafe gegen Pharmahersteller teilweise auf

EU-Gericht hebt Kartellstrafe gegen Pharmahersteller teilweise auf


(dpa) Das EU-Gericht hat eine Kartellstrafe gegen das französische Pharmaunternehmen Servier und eine Reihe weiterer Hersteller wegen Wettbewerbsverzerrungen teilweise aufgehoben. Der EU-Kommission seien bei ihrer Entscheidung im Jahr 2014 Fehler unterlaufen, urteilten die Luxemburger Richter am Mit...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

J&J says its psoriasis drug superior to Novartis' in study

J&J says its psoriasis drug superior to Novartis' in study


Johnson & Johnson said its drug Tremfya was found to be more effective than a rival medicine from Novartis AG in reducing the severity and affected area in adults with moderate-to-severe plaque psoriasis in a late-stage study. REUTERS: Johnson & Johnson said its drug, Tremfya, was found to be more effective than a rival medicine from Novartis AG in reducing the severity and affected area in adults with moderate-to-severe plaque psoriasis in a late-stage study.



from Biotech News
Share:

Lonza gründet in China strategische Produktionsstätte für Biopharmazeutika

Lonza gründet in China strategische Produktionsstätte für Biopharmazeutika


Lonza hat heute eine Vereinbarung mit GE Healthcare bekanntgegeben, in deren Rahmen GE Healthcare Lonza ein Biologika-Werk in Guangzhou (CN) bereitstellen wird. Da das Werk Gegenstand einer grösseren Bioproduktionsinitiative zwischen GE Healthcare und dem Guangzhou Development District (GDD) ist, wi...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Cellect Biotech/S (Apop) PT Set at $12.00 by HC Wainwright

Cellect Biotech/S (Apop) PT Set at $12.00 by HC Wainwright


The firm presently has a "buy" rating on the stock. HC Wainwright's price target indicates a potential upside of 280.95% from the stock's current price.



from Biotech News
Share:

How Indian biotech is driving innovation

How Indian biotech is driving innovation


Bolstered by government support, a wealth of investment and an eager graduate workforce, the country's biotechnology industry is booming. Crop researchers at an institute near Hyderabad, India, are using biotechnology to boost yields of pigeon-pea plants, a food crop and important protein source.



from Biotech News
Share:

Physician assistant faces U.S. trial over Insys opioid kickbacks

Physician assistant faces U.S. trial over Insys opioid kickbacks


A former physician assistant is set to face trial in New Hampshire on Wednesday over charges he accepted kickbacks from Insys Therapeutics Inc ( FILE PHOTO: A box of the Fentanyl-based drug Subsys, made by Insys Therapeutics Inc, is seen in an undated photograph provided by the U.S. Attorney's Office for the Southern District of Alabama. U.S. Attorney's Office for the Southern District of Alabama/Handout via REUTERS A federal jury in Concord, New Hampshire, will hear opening statements in the trial of Christopher Clough, whose case could provide a glimpse into some of the evidence prosecutors plan to use in the upcoming trial of six former Insys executives and managers.



from Biotech News
Share:

Oncolytics Biotech, Inc. (ONCY) Expected to Announce Earnings of -$0.19 Per Share

Oncolytics Biotech, Inc. (ONCY) Expected to Announce Earnings of -$0.19 Per Share


Brokerages expect Oncolytics Biotech, Inc. to announce earnings per share for the current fiscal quarter, according to Zacks Investment Research . Zero analysts have provided estimates for Oncolytics Biotech's earnings.



from Biotech News
Share:

Amid opioid crisis, methamphetamine deaths now on rise

Amid opioid crisis, methamphetamine deaths now on rise


This 2018 photo provided by the Cannon River Drug and Violent Task Force shows a box containing methamphetamine. Authorities said Friday, Sept.



from Biotech News
Share:

Fourth Flu Death Of 2018 Reported In Arkansas

Fourth Flu Death Of 2018 Reported In Arkansas


The department's weekly flu report noted that the state has reported "sporadic" activity to the Centers for Disease Control and Prevention for a geographic spread and a "minimal" level of intensity for week 49. The fourth victim lived in the southwest part of Arkansas. The ADH was not sure if they had gotten a flu vaccine this season.



from Biotech News
Share:

Finanzen: Geld leihen : Geld leihen

Wer kurzfristig Geld braucht, kann Dispo und Kreditkarte nutzen oder einen Privatkredit aufnehmen. Ein teurer Sofortkredit kommt nur im Notfall infrage.

from Finanztip Feed
Supported by Video Collection
Share:

Shingles vaccine shortage in Connecticut

Shingles vaccine shortage in Connecticut


A new vaccine to protect against a painful disease known as shingles is a victim of its own success and nearly impossible to find in Connecticut and many parts of the United States. The vaccine, produced solely by GlaxoSmithKline and called Shingrix, became broadly available in the United States about a year ago.



from Biotech News
Share:

Capital World Investors Has $1.14 Billion Position in Hologic, Inc.

Capital World Investors Has $1.14 Billion Position in Hologic, Inc.


Capital World Investors boosted its position in Hologic, Inc. by 2.5% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission . The fund owned 27,808,896 shares of the medical equipment provider's stock after buying an additional 671,524 shares during the period.



from Biotech News
Share:

Kein Verbot des Arzneimittel-Versands

Kein Verbot des Arzneimittel-Versands


(dpa) Patienten in Deutschland können verschreibungspflichtige Medikamente auch künftig bei einer Online-Apotheke bestellen. Das von der Koalition ursprünglich angepeilte Verbot des Versandhandels ist vom Tisch. Es sei europarechtlich unwägbar, ob und wie ein solches Verbot umgesetzt werden könne, e...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Huge new study will track effects of screen time on kids' brains

Huge new study will track effects of screen time on kids' brains


Already the National Institutes of Health has found "significant differences" in the brains of children who spend excessive time online. Anywhere you go, you will see children and teens with tablets or smartphones in their hands.



from Biotech News
Share:

Suicide rates are up

Suicide rates are up


Vermont rates of suicide are higher than the rates of neighboring states and the New England region. The overall rate throughout the United States has been increasing.



from Biotech News
Share:

Merck erhält „Orphan Drug“-Status für bifunktionale Immuntherapie

Merck erhält „Orphan Drug“-Status für bifunktionale Immuntherapie


Merck hat bekannt gegeben, dass die US-amerikanische Zulassungsbehörde FDA (Food and Drug Administration) die bifunktionale Immuntherapie M7824 als „Orphan Drug“ für die Behandlung von Tumoren des biliären Trakts (BTC) eingestuft hat. Dies ist der erste regulatorische Status für die Prüfsubstanz des...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

La Jolla Pharmaceutical (LJPC) Lowered to Strong Sell at BidaskClub

La Jolla Pharmaceutical (LJPC) Lowered to Strong Sell at BidaskClub


LJPC has been the topic of a number of other reports. ValuEngine upgraded La Jolla Pharmaceutical from a hold rating to a buy rating in a research report on Saturday, October 27th.



from Biotech News
Share:

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings


The distribu... )--A Global Payments Inc. , fornecedora lider mundial de tecnologia de pagamento e solucoes de software tem o prazer de anunciar que sua empresa TouchNet foi nomea... )--Global Payments Inc. , fournisseur leader mondial de solutions technologiques et logicielles de paiement, est ravi d'annoncer que sa division TouchNet a ete de... Select Income REIT Announces the Record Date for the Distribution of 45 Million Common Shares of Industrial Logistics Properties Trust )--Select Income REIT today announced that it has set the record date for the distribution of all its 45,000,000 common shares of beneficial interest of I... )--Fifth Third Bancorp announced today that Eric S. Smith, currently the Chicago regional president of Fifth Third Bank, will transition to chief operating ... )--Enzo Biochem, Inc. , an integrated diagnostics and therapeutics company, today reported ... (more)



from Biotech News
Share:

Finanzen: Aktienrückkauf : Aktienrückkauf

Bei einem Aktienrückkauf erwirbt ein Unternehmen Anteilsscheine von Aktionären zurück. Oft winkt eine Prämie. Wer dabei bleibt, kann von höheren Aktienkursen profitieren.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Kredite von Privat : Privatkredit

Geld von Verwandten oder guten Bekannten zu leihen, kann billiger sein als bei der Bank. Es gibt aber auch Online-Plattformen, die Privatkredite vermitteln.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: ETF-Sparplan : ETF-Sparplan

Sparpläne mit Aktien-Indexfonds sind eine flexible und preisgünstige Ergänzung zu sicheren Anlagen wie Tagesgeld oder Festgeld. Wir haben Sparpläne unter die Lupe genommen und zeigen günstige Angebote.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: MSCI ACWI : MSCI ACWI - ETFs auf den MSCI All Countries World Index

Der MSCI All Countries World Index (MSCI ACWI) bündelt Aktien der 2.500 größten Unternehmen aus Industrie- und Schwellenländern. Finanztip empfiehlt börsennotierte Indexfonds (ETFs) auf den MSCI ACWI von SPDR, Lyxor und iShares.

from Finanztip Feed
Supported by Video Collection
Share:

Reviewing BioCardia

Reviewing BioCardia


BioCardia and Acorda Therapeutics are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk. Acorda Therapeutics has a consensus target price of $25.75, suggesting a potential upside of 39.26%.



from Biotech News
Share:

Finanzen: iPhone günstig kaufen : iPhone kaufen

Apple verlangt für manche iPhone-Modelle vierstellige Beträge. Doch so viel Geld müssen Sie nicht ausgeben. Es gibt Wege, günstiger an ein iPhone zu kommen.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Ratenkredit Targobank : Targobank Kredit

Der Zinssatz beim Online-Kredit der Targobank entspricht dem Durchschnitt. Für die Filialkredite gilt dies keinesfalls. Sie sind viel zu teuer.

from Finanztip Feed
Supported by Video Collection
Share:

Record count reported for mysterious paralyzing illness

Record count reported for mysterious paralyzing illness


Fortunately, the disease remains rare. The Centers for Disease Control and Prevention on Monday reported 158 confirmed cases so far this year.



from Biotech News
Share:

TOP 3 MÖGLICHKEITEN einen KREDIT schnell ZU BEKOMMEN 2019!

In diesem Beitrag beschreiben wir, die TOP 3 Möglichkeiten an einen schnellen Kredit zu kommen, um die unvorhergesehene Ausgaben rechtzeitig zu finanzieren. Sie bekommen Bargeld um Reparatur eines Autos zu erledigen, oder einen anderen Kredit schnell zu tilgen. Read More →

The post TOP 3 MÖGLICHKEITEN einen KREDIT schnell ZU BEKOMMEN 2019! appeared first on Schufa Öffnungszeiten Berlin.



from Schufa Öffnungszeiten Berlin https://ift.tt/2QQymYY
via IFTTT
Share:

Markets Live: ASX closes 23 points higher

Markets Live: ASX closes 23 points higher


At 3pm the S&P/ASX 200 was hovering around 5555 points, then jumped up to end the day 23 points higher at 5575 . CSL did a lot of heavy lifting today with a 2 per cent rise to $180.38 that added 6.3 points to the index.



from Biotech News
Share:

Aristotle Capital Boston LLC Purchases 9,490 Shares of Cohen & Steers, Inc.

Aristotle Capital Boston LLC Purchases 9,490 Shares of Cohen & Steers, Inc.


Aristotle Capital Boston LLC lifted its stake in shares of Cohen & Steers, Inc. by 14.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission . The firm owned 76,487 shares of the asset manager's stock after acquiring an additional 9,490 shares during the period.



from Biotech News
Share:

'We're Fighting For Our Lives' - Patients Protest Sky-High Insulin Prices

'We're Fighting For Our Lives' - Patients Protest Sky-High Insulin Prices


"We had coolers of Gatorade and water for people to always have access to," Lautner remembers of her job as a ground services agent. "But the amount of thirst that I felt was just incredible."



from Biotech News
Share:

The Singh Brothers' Feud Gets Physical: Malvinder Accuses Shivinder Of Assault

The Singh Brothers' Feud Gets Physical: Malvinder Accuses Shivinder Of Assault


Malvinder Mohan Singh and Shivinder Mohan Singh of Fortis Healthcare at the Delhi launch of Kalli Purie's book 'Confessions of Serial Dieter' in January 2012. Brothers Malvinder and Shivinder Singh, who once owned a pharma fortune in excess of $2 billion, have a knack for staying in the news despite having lost most of it.



from Biotech News
Share:

Finanzen: So finden Sie den besten Spritpreis : Billig tanken

Autofahrer ärgern sich oft über die hohen Benzinkosten. Doch beim Tanken gibt es erhebliches Sparpotenzial. Wir zeigen die Preistricks der Ölkonzerne.

from Finanztip Feed
Supported by Video Collection
Share:

Gilead Sciences to hire Roche executive O'Day as new CEO: source

Gilead Sciences to hire Roche executive O'Day as new CEO: source


Drugmaker Gilead Sciences Inc will name Roche Holding AG executive Daniel O'Day as its new chief executive officer, according to a source familiar with the matter. The news of O'Day's hiring comes about four months after Gilead said in July that it's Chief Executive John Milligan and Chairman John Martin would step down at the end of the year.



from Biotech News
Share:

Head-To-Head Survey: Collplant Holdi/S

Head-To-Head Survey: Collplant Holdi/S


COLLPLANT HOLDI/S and Precision Therapeutics are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, valuation, analyst recommendations, risk and institutional ownership. This is a summary of current recommendations and price targets for COLLPLANT HOLDI/S and Precision Therapeutics, as reported by MarketBeat.



from Biotech News
Share:

Finanzen: Zugverspätung: So erhalten Sie eine Entschädigung von der Bahn : Fahrgastrechte im Bahnverkehr

Ein Sommergewitter nach Hitze - und schon ist die Zugverbindung lahmgelegt. Fahrgäste haben ab 60 Minuten Verzögerung Anspruch auf Entschädigung.

from Finanztip Feed
Supported by Video Collection
Share:

Roche bekommt neuen Pharmachef

Roche bekommt neuen Pharmachef


(dpa-AWP) Personalwechsel in der Führungsetage des Pharmakonzerns Roche: Der langjährige Pharmachef Daniel O'Day wird zum Jahresende das Schweizer Unternehmen verlassen, wie Roche am Montag in Basel mitteilte. Sein Nachfolger wird William Anderson, der aktuell die Geschicke der US-Tochter Genentech ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Antibabypille zurückgerufen: Ungewollte Schwangerschaft droht

Antibabypille zurückgerufen: Ungewollte Schwangerschaft droht


(dpa) Wegen falscher Beschriftung wurde eine noch unbekannte Zahl von Packungen der Antibabypille «Trigoa» zurückgerufen. Weil einige Durchdrückpackungen hinten falsch markiert seien, drohten ungewollte Schwangerschaften, teilte das Berliner Landesamt für Gesundheit und Soziales (Lageso) als zuständ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Capital Bank & Trust Co Raises Position in AstraZeneca plc

Capital Bank & Trust Co Raises Position in AstraZeneca plc


Capital Bank & Trust Co boosted its holdings in AstraZeneca plc by 2.1% during the third quarter, Holdings Channel reports. The fund owned 1,732,616 shares of the company's stock after acquiring an additional 36,451 shares during the period.



from Biotech News
Share:

Sartorius-Aufsichtsrat beruft zwei neue Vorstände

Sartorius-Aufsichtsrat beruft zwei neue Vorstände


image description
Der Aufsichtsrat der Sartorius AG hat in seiner Sitzung Änderungen im Vorstand beschlossen. Mit Wirkung zum 1. Januar 2019 werden Dr. René Fáber als Spartenleiter Bioprocess Solutions sowie Gerry Mackay als Spartenleiter Lab Products & Services als neue Mitglieder des Vorstands bestellt. René Fáber ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Franklin Resources Inc. Sells 3,239,216 Shares of Bristol-Myers Squibb Co

Franklin Resources Inc. Sells 3,239,216 Shares of Bristol-Myers Squibb Co


Franklin Resources Inc. reduced its position in Bristol-Myers Squibb Co by 82.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission . The institutional investor owned 702,909 shares of the biopharmaceutical company's stock after selling 3,239,216 shares during the quarter.



from Biotech News
Share:

Farmers National Bank Buys 5,031 Shares of Pfizer Inc.

Farmers National Bank Buys 5,031 Shares of Pfizer Inc.


Farmers National Bank increased its stake in shares of Pfizer Inc. by 4.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 120,730 shares of the biopharmaceutical company's stock after purchasing an additional 5,031 shares during the period.



from Biotech News
Share:

Immunomedics (IMMU) Receives Buy Rating from Cowen

Immunomedics (IMMU) Receives Buy Rating from Cowen


's stock had its "buy" rating reaffirmed by Cowen in a research note issued to investors on Friday. They currently have a $30.00 target price on the biopharmaceutical company's stock.



from Biotech News
Share:

$0.31 EPS Expected for Neogen Co. (NEOG) This Quarter

$0.31 EPS Expected for Neogen Co. (NEOG) This Quarter


Brokerages expect Neogen Co. to post earnings of $0.31 per share for the current fiscal quarter, according to Zacks Investment Research .



from Biotech News
Share:

Dimensional Fund Advisors LP Decreases Position in Myriad Genetics, Inc.

Dimensional Fund Advisors LP Decreases Position in Myriad Genetics, Inc.


Dimensional Fund Advisors LP decreased its position in shares of Myriad Genetics, Inc. by 13.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,642,281 shares of the company's stock after selling 412,982 shares during the period.



from Biotech News
Share:

Cardinal Health Inc (CAH) Position Reduced by Pictet Asset Management Ltd.

Cardinal Health Inc (CAH) Position Reduced by Pictet Asset Management Ltd.


Pictet Asset Management Ltd. lowered its holdings in shares of Cardinal Health Inc by 5.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission . The firm owned 167,771 shares of the company's stock after selling 9,100 shares during the period.



from Biotech News
Share:

Spectrum Pharmaceuticals, Inc. (SPPI) Director Sells $91,350.00 in Stock

Spectrum Pharmaceuticals, Inc. (SPPI) Director Sells $91,350.00 in Stock


Spectrum Pharmaceuticals, Inc. Director Anthony E. Maida III sold 7,250 shares of the firm's stock in a transaction that occurred on Thursday, December 6th. The stock was sold at an average price of $12.60, for a total value of $91,350.00.



from Biotech News
Share:

Officials to study scooter crashes in Austin

Officials to study scooter crashes in Austin


Officials in Austin are working with the Atlanta-based U.S. Centers for Disease Control and Prevention to study how to prevent dockless scooter crashes and patterns tied to the crashes. Dr. Philip Huang with Austin Public Health says CDC epidemiologists will give questionnaires to people injured by scooter crashes in a search for trends tied to the severity of the injuries.



from Biotech News
Share:

Mesh destroys 'intimacy in marriage' but Kiwi victim cannot sue

Mesh destroys 'intimacy in marriage' but Kiwi victim cannot sue


New Zealand women suffering catastrophic complications from surgical mesh devices were barred from suing Johnson & Johnson for what they say was a defective product. The judge said ACC could cover their claims.



from Biotech News
Share:

Fentanyl Billionaire No More: John Kapoor's Net Worth Drops Below $1 Billion

Fentanyl Billionaire No More: John Kapoor's Net Worth Drops Below $1 Billion


The founder of embattled fentanyl manufacturer Insys Therapeutics is no longer a billionaire. Five years after joining the Forbes Billionaires list, John Kapoor now has a net worth of $875million.



from Biotech News
Share:

Gilead Sciences, Inc. (GILD) Shares Sold by Fifth Third Bancorp

Gilead Sciences, Inc. (GILD) Shares Sold by Fifth Third Bancorp


Fifth Third Bancorp reduced its stake in Gilead Sciences, Inc. by 2.4% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 793,885 shares of the biopharmaceutical company's stock after selling 19,542 shares during the quarter.



from Biotech News
Share:

UPDATE 1-Moderna, largest biotech to go public, fails to impress in market debut

UPDATE 1-Moderna, largest biotech to go public, fails to impress in market debut


Both the Dow Jones Industrial Average .DJI and the S&P 500 .SPX were down 1.5 percent, while the Nasdaq biotechnology index .NBI fell 2.6 percent. Moderna's shares opened at $22.00, 4.3 percent below their initial public offering price of $23.00 per share.



from Biotech News
Share:

Hologic Sees Unusually High Options Volume

Hologic Sees Unusually High Options Volume


Hologic, Inc. was the recipient of unusually large options trading on Thursday. Stock traders purchased 6,771 call options on the company.



from Biotech News
Share:

Contrasting Pharmacyte Biotech

Contrasting Pharmacyte Biotech


Pharmacyte Biotech and Canopy Growth are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability. 0.1% of Pharmacyte Biotech shares are owned by institutional investors.



from Biotech News
Share:

Aviance Capital Partners LLC Boosts Stake in Johnson & Johnson

Aviance Capital Partners LLC Boosts Stake in Johnson & Johnson


Aviance Capital Partners LLC raised its stake in Johnson & Johnson by 1.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 23,097 shares of the company's stock after acquiring an additional 419 shares during the quarter.



from Biotech News
Share:

Finanzen: Investmentsteuerreformgesetz : Investmentsteuerreformgesetz

Ab 2018 werden alle Fonds und ETFs steuerlich gleich behandelt. Abgeltungssteuer fällt künftig jährlich auf eine Pauschale an. Worauf Sparer achten sollten.

from Finanztip Feed
Supported by Video Collection
Share:

For New Mexico's autistic children, diagnosis may take years - putting a hold on treatment

For New Mexico's autistic children, diagnosis may take years - putting a hold on treatment


To be medically diagnosed for autism, families can wait years before being able to see someone at UNM, the primary provider of medical diagnoses. For New Mexico's autistic children, diagnosis may take years - putting a hold on treatment To be medically diagnosed for autism, families can wait years before being able to see someone at UNM, the primary provider of medical diagnoses.



from Biotech News
Share:

Finanzen: Düsseldorfer Tabelle : Düsseldorfer Tabelle für 2018 und 2019

Wenn Sie wissen möchten, wie viel Unterhalt Sie nach der Trennung oder Scheidung für die Kinder zahlen müssen, hilft Ihnen die aktuelle Düsseldorfer Tabelle.

from Finanztip Feed
Supported by Video Collection
Share:

Nine more people added to E coli infection investigation in US

Nine more people added to E coli infection investigation in US


Romaine lettuce is displayed on a grocery store shelf in New York City on Nov 21, 2018. ATLANTA: The US Centers for Disease Control and Prevention said on Thursday an additional nine people are being investigated in connection with the multistate outbreak of E coli infections related to romaine lettuce.



from Biotech News
Share:

Finanzen: Minijob : Minijob

Monatlich bis 450 Euro dürfen Minijobber sozialversicherungs- und steuerfrei verdienen. Das gilt nur für eine geringfügige Beschäftigung.

from Finanztip Feed
Supported by Video Collection
Share:

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings


In the order granting Edeniq's motion, ... Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of McDermott International, Inc. Investors )--Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of McDermott International, Inc. Investors )--Weight loss pioneer, Dr. Marshall Stamper, died earlier this week surrounded by his family. He was eighty-nine years old.



from Biotech News
Share:

Finanzen: Hundehaftpflicht : Hundehaftpflicht

Es muss kein Biss sein, der Vierbeiner braucht nur mal ausbüxen. Dann müssen Sie alle Schäden tragen, die Ihr Hund verursacht.

from Finanztip Feed
Supported by Video Collection
Share:

Mississippi sues opioid distributors over crisis

Mississippi sues opioid distributors over crisis


More than half a million people died between 2000 and 2015 from opioid use. In 2017 the U.S. Department of Health and Human Services declared the national opioid crisis a public health emergency.



from Biotech News
Share:

Woman who became unresponsive after arrest in La Jolla dies

Woman who became unresponsive after arrest in La Jolla dies


A 24-year-old woman who went into medical distress after being arrested in La Jolla last week has died, police said Thursday. Officers pulled over Aleah Mariah Jenkins during a traffic stop on La Jolla Village Drive near Interstate 5 about 4 p.m. on Nov. 27. When they determined she was wanted on a warrant for possessing methamphetamine, they arrested her, San Diego police Lt.



from Biotech News
Share:

J&J unit to pay US$360 million to US to resolve charity kickback probe

J&J unit to pay US$360 million to US to resolve charity kickback probe


A unit of Johnson & Johnson has agreed to pay the U.S. government US$360 million to resolve an investigation into its financial support of charities that help Medicare patients cover out-of-pocket drug costs, the U.S. Justice Department said on Thursday. FILE PHOTO: The Johnson and Johnson logo is seen at an office building in Singapore January 17, 2018.



from Biotech News
Share:

Paralyzed in stage accident, Chicago-area band director tries to...

Paralyzed in stage accident, Chicago-area band director tries to...


Prominent local clarinet player and band director Ralph Wilder with his clarinet at his home in Northfield on Nov. 28, 2018. Wilder, a mainstay in the local music scene for decades, broke his back when a projector screen fell on him at Northeastern Illinois University.



from Biotech News
Share:

Rare nervous system disease confirmed in Michigan

Rare nervous system disease confirmed in Michigan


The Michigan Department of Health and Human Services is reporting that the Centers for Disease Control and Prevention is investigating seven cases of Acute Flaccid Myelitis .



from Biotech News
Share:

Courts Fight Back Against Rising Tide of Federal Disclosure Suits

Courts Fight Back Against Rising Tide of Federal Disclosure Suits


Summary : In the past few years, there has been a dramatic rise in the number of M&A disclosure lawsuits filed in federal court. Recently, courts have begun to fight back against this nuisance litigation using different approaches.



from Biotech News
Share:

Finanzen: Bezahlen im Internet : Sicher bezahlen im Internet

Möglichkeiten, im Internet zu bezahlen, gibt es viele. Sicher und sinnvoll sind aber nur ein paar davon. Wir zeigen, welche.

from Finanztip Feed
Supported by Video Collection
Share:

This Peninsula biotech foresaw deals worth $3 billion. Now it's lining up a $57 million merger

This Peninsula biotech foresaw deals worth $3 billion. Now it's lining up a $57 million merger


The reverse merger between Redwood City-based OncoMed and Mereo BioPharma Group plc will give the London company a U.S. stock listing and seven experimental drugs. If the deal closes as expected in first-half 2019, it would close the books on OncoMed and validate the biotech industry's risk-stepping "biobucks" deals.



from Biotech News
Share:

Finanzen: Wertpapierdepot Onvista Bank : Onvista Bank Wertpapierdepot

Die Onvista Bank bietet ein Wertpapierdepot mit Festpreisen. Kunden können Aktien, ETF und Co. für 6,50 Euro pro Auftrag handeln.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Weltsparen : Weltsparen

Minuspunkte gibt's bei der Sicherheit der Banken.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Zinspilot : Zinspilot

Die Zinsplattform Zinspilot vermittelt Angebote in Europa. Aber nicht alle sind empfehlenswert.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Savedo : Savedo

Der Einlagenvermittler Savedo verspricht hohe Zinsen aufs Festgeld. Er setzt dabei auf Banken aus dem europäischen Ausland. Lesen Sie hier, was Sie zu diesem Angebot wissen müssen.

from Finanztip Feed
Supported by Video Collection
Share:

Takeda Shareholders Approve Shire Megadeal

Takeda Shareholders Approve Shire Megadeal


Takeda Pharmaceutical Co. shareholders voted in favor of its megadeal to buy Europe's Shire PLC on Wednesday, crushing an opposition campaign that sought to derail the biggest overseas acquisition by a Japanese company.



from Biotech News
Share:

Finanzen: Erwerbsminderungsrente : Erwerbsminderungsrente

Die gesetzliche Erwerbsminderungsrente reicht im Notfall kaum aus. Besonders jüngere Menschen müssen zusätzlich vorsorgen.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Direktversicherung als betriebliche Altersvorsorge : Direktversicherung

Die Direktversicherung ist eine Form der betrieblichen Altersvorsorge. Arbeitnehmer können Teile ihres Bruttogehalts in die Police einzahlen und Steuern und Abgaben sparen.

from Finanztip Feed
Supported by Video Collection
Share:

Bayer-Beschäftigte sollen bei Jobabbau bis März Klarheit haben

Bayer-Beschäftigte sollen bei Jobabbau bis März Klarheit haben


(dpa) Bayer will für den geplanten massiven Personalabbau Mitarbeiter in den Ruhestand schicken. «Es wird ein Programm 57+ geben, wonach Bayer-Beschäftigte mit 57 Jahren in den Ruhestand gehen können», sagte Oliver Zühlke, Chef des Bayer-Gesamtbetriebsrats, der «Rheinischen Post» (Mittwoch). Das sei...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Grünes Licht für neuen Pharmariesen

Grünes Licht für neuen Pharmariesen


(dpa-AFX) Die Übernahme des irischen Pharmakonzerns Shire durch den japanischen Konkurrenten Takeda ist perfekt. Auch die Aktionäre von Shire stimmten der Fusion mit über 99 Prozent zu, wie Shire am Mittwoch mitteilte. Zuvor hatten auch die Anteilseigner von Takeda mehrheitlich mit 88 Prozent zugest...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Overnight Health Care: Top biotech lobbyist sees industry under...

Overnight Health Care: Top biotech lobbyist sees industry under...


The Hill sat down with James Greenwood, the CEO of the Biotechnology Innovation Organization, to talk about the group's priorities with a Democratic House looming. Also today, a new bill from the incoming chairman and current ranking member of the Senate Finance Committee gives a hint at the committee's new direction next year.



from Biotech News
Share:

Acorda Launches Art Initiative to Foster Better Conversations About Parkinson's Symptoms

Acorda Launches Art Initiative to Foster Better Conversations About Parkinson's Symptoms


Dec 5, 2018--Acorda Therapeutics, Inc. today launched Framing OFF Through Art a , a new initiative that uses the power of art to allow people with Parkinson's to help recognize and articulate their OFF period experiences. This initiative builds on Acorda's "Live Well.



from Biotech News
Share:

SPDR S&P Biotech Etf (Xbi) Stake Lessened by Assetmark Inc.

SPDR S&P Biotech Etf (Xbi) Stake Lessened by Assetmark Inc.


Assetmark Inc. lowered its stake in shares of SPDR S&P Biotech ETF by 34.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission . The fund owned 830,727 shares of the exchange traded fund's stock after selling 433,286 shares during the period.



from Biotech News
Share:

JNJ-AbbVie cancer drug Imbruvica succeeds in late-stage trial

JNJ-AbbVie cancer drug Imbruvica succeeds in late-stage trial


Johnson and Johnson said on Tuesday a combination therapy containing its blockbuster cancer drug Imbruvica significantly improved survival in blood cancer patients, compared with drugs currently used as the standard of care. In the study, Imbruvica, jointly sold with AbbVie Inc, was given to newly diagnosed chronic lymphocytic leukemia patients aged 70 or younger, in combination with Roche AG's Rituxan.



from Biotech News
Share:

Finanzen: Visa oder Mastercard : Visa oder Mastercard

Ob Sie eine Kreditkarte von Mastercard oder Visa wählen, spielt keine Rolle. Wichtig sind die Konditionen – und die legt Ihre Bank fest.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Gold & Platin Kreditkarten : Goldene Kreditkarte

Wenn Sie Ihre Kreditkarte häufig nutzen, können Sie mit einer Gold- und Platinkarte Geld sparen. Wir haben die beliebtesten Angebote für Sie unter die Lupe genommen.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Visa-Card : Visa-Card

Kreditkarten von Visa werden weltweit akzeptiert, egal ob an Geldautomaten oder in Geschäften. Es gibt sie in unterschiedlichen Ausführungen, nicht immer ist bei der Kreditkarte ein Kredit dabei.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Handy gebraucht kaufen : Gebrauchte Handys kaufen

Wie beim Autokauf ist es oft schlau, Smartphones gebraucht zu kaufen. Wir haben darauf spezialisierte Händler verglichen.

from Finanztip Feed
Supported by Video Collection
Share:

Docs: Shingles shot can come with side effects

Docs: Shingles shot can come with side effects


This image provided by GlaxoSmithKline shows the company's Shingrix vaccine. Though the vaccine has a high rate of effectiveness, local doctors said it also has a high rate of side effects.



from Biotech News
Share:

Analysts Expect Vertex Pharmaceuticals Incorporated (VRTX) to Announce $1.05 Earnings Per Share

Analysts Expect Vertex Pharmaceuticals Incorporated (VRTX) to Announce $1.05 Earnings Per Share


Analysts predict that Vertex Pharmaceuticals Incorporated will report earnings of $1.05 per share for the current quarter, according to Zacks . Ten analysts have made estimates for Vertex Pharmaceuticals' earnings, with the lowest EPS estimate coming in at $0.93 and the highest estimate coming in at $1.15.



from Biotech News
Share:

Takeda bekommt grünes Licht für die Übernahme von Shire

Takeda bekommt grünes Licht für die Übernahme von Shire


(dpa-AFX) Der japanische Pharmakonzern Takeda hat von seinen Aktionären die Zustimmung für die Übernahme des irischen Konkurrenten Shire erhalten. Mindestens 88 Prozent der Anteilseigner hätten auf dem eigens dafür anberaumten Aktionärstreffen für die Übernahme gestimmt, teile das japanische Unterne...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Gutes Jahr 2018, verhaltener Ausblick für 2019

Gutes Jahr 2018, verhaltener Ausblick für 2019


Das Jahr 2018 ist für die chemisch-pharmazeutische Industrie in Deutschland gut verlaufen. Diese Branchenbilanz hat der Verband der Chemischen Industrie (VCI) auf seiner Jahrespressekonferenz in Frankfurt gezogen. Der Branchenumsatz erhöhte sich um 4,5 Prozent auf 204 Milliarden Euro und überstieg d...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Mylan to recall all batches of blood pressure medicine valsartan in U.S.

Mylan to recall all batches of blood pressure medicine valsartan in U.S.


Mylan NV said on Tuesday it is expanding a nationwide voluntary recall of its blood pressure medicine valsartan to include all lots, two weeks after it recalled select batches. The drugmaker said it was recalling 104 additional lots "out of an abundance of caution" after the valsartan-containing products were found to contain traces of a probable cancer-causing impurity.



from Biotech News
Share:

Evotec und LEO Pharma bilden Forschungsallianz im Bereich Hautkrankheiten

Evotec und LEO Pharma bilden Forschungsallianz im Bereich Hautkrankheiten


Evotec AG gab den Beginn einer integrierten Wirkstoffforschungsallianz mit LEO Pharma bekannt. Ziel ist es, neue Leitstrukturen zu generieren, die auf innovative und für verschiedene dermatologische Indikationen bedeutende Zielstrukturen einwirken. Die Dauer der Zusammenarbeit beträgt zunächst zwei ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Booming U.S. Biotech Could Buckle Next in China Trade Tango

Booming U.S. Biotech Could Buckle Next in China Trade Tango


Increasing wariness in Washington over China's investments in U.S. biotechnology companies may cool a hot source of capital for medical startups. Chinese investors have been a mainstay of recent fundraising by private biotechnology firms.



from Biotech News
Share:

LI biotech firm plans to quadruple its space, expand hiring

LI biotech firm plans to quadruple its space, expand hiring


Acutis Diagnostics has grown from 2 employees to more than 100 in three years. The opioid crisis has helped fuel the firm's rapid growth, the CEO says.



from Biotech News
Share:

UPDATE 1-Amgen antibody shows promise in myeloma trial, gets FDA fast track

UPDATE 1-Amgen antibody shows promise in myeloma trial, gets FDA fast track


Amgen Inc, updating the first trial of its bispecific antibody for multiple myeloma, said on Monday seven out of 10 patients given the second-highest dose of AMG420 responded to the drug, including four with no detectable cancer. FILE PHOTO - An Amgen sign is seen at the company's office in South San Francisco, California in this October 21, 2013 file photo.



from Biotech News
Share:

Ampco-Pittsburgh Corp (AP) Director James J. Abel Buys 7,000 Shares

Ampco-Pittsburgh Corp (AP) Director James J. Abel Buys 7,000 Shares


Ampco-Pittsburgh Corp Director James J. Abel acquired 7,000 shares of the stock in a transaction on Friday, November 30th. The shares were acquired at an average price of $4.12 per share, with a total value of $28,840.00.



from Biotech News
Share:

Workshop „Unbegleitete, minderjährige Flüchtlinge erfolgreich integrieren – aber wie?“ am 6. Oktober in der Brunsviga

Workshop „Unbegleitete, minderjährige Flüchtlinge erfolgreich integrieren – aber wie?“ am 6. Oktober in der Brunsviga


Impressum Datenschutz English LogIn Schnellzugriff Web-LogIn Webmail TUgether Infoportal Personen ProfessorInnen Institute Studiengänge Mensa Fakultäten Fakultät für Geistes- und Erziehungswissenschaften Koordination Sprachlernunterstützung für Flüchtlinge Aktuelles Allgemeine Informationen ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

WHO: US experts not needed to fight Ebola outbreak in Congo

WHO: US experts not needed to fight Ebola outbreak in Congo


The head of the World Health Organization says it doesn't need experts from the Centers for Disease Control and Prevention or any other U.S. government agency to fight the deadly Ebola outbreak in Congo, insisting: "We can cover it." WHO Director-General Tedros Adhanom Ghebreyesus says the U.N. health agency mostly needs the United States to continue the financial and other support it has provided.



from Biotech News
Share:

Fort Lauderdale Takes on Purdue Pharma, Walgreens, CVS, McKesson, and Others Over Opioid Crisis

Fort Lauderdale Takes on Purdue Pharma, Walgreens, CVS, McKesson, and Others Over Opioid Crisis


"Within the next hour, six Americans will die from opioid overdoses; two babies will be born dependent on opioids and begin to go through withdrawal; and drug manufacturers will earn over $2.7 million from the sale of opioids," lawyers for the City of Fort Lauderdale wrote in a federal lawsuit filed November 20 against Purdue Pharma and a litany of ... (more)



from Biotech News
Share:

GlaxoSmithKline kauft US-Krebsspezialisten für 5,1 Milliarden Dollar

GlaxoSmithKline kauft US-Krebsspezialisten für 5,1 Milliarden Dollar


(dpa-AFX) Der Pharmakonzern GlaxoSmithKline (GSK) erweitert mit einem Milliardenzukauf sein Krebsgeschäft. Der Konzern kauft für bis zu 5,1 Milliarden US-Dollar den amerikanischen Onkologiespezialisten Tesaro, wie GSK am Montag in London mitteilte. Die Übernahme werde das bereinigte Ergebnis je Akti...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

CAR T-Therapie kann zu dauerhaften Remissionen beim Non-Hodgkin-Lymphom führen

CAR T-Therapie kann zu dauerhaften Remissionen beim Non-Hodgkin-Lymphom führen


In einer Aktualisierung einer globalen klinischen Studie, die sich von Philadelphia bis auf vier Kontinente erstreckt, führte die chimäre Antigenrezeptor-(CAR)-T-Zelltherapie Kymriah® (tisagenlecleucel, ehemals CTL019) zu lang anhaltenden Remissionen bei Patienten mit rezidivierendem/refraktärem (r/...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

KI-Forscher arbeiten gemeinsam an der Entwicklung des "ImageNet" der generativen Wirkstoffforschung

KI-Forscher arbeiten gemeinsam an der Entwicklung des "ImageNet" der generativen Wirkstoffforschung


image description
Insilico Medicine, ein Unternehmen der künstlichen Intelligenz, das eine End-to-End-Pipeline zur Entdeckung von Medikamenten für altersbedingte Krankheiten entwickelt, kündigte eine offene Forschungskooperation an. Forscher sind eingeladen, einen Beitrag zur neuen Plattform MOSES (Molecular Sets) zu...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

UPDATE 3-GSK slides after buying cancer firm Tesaro for hefty $5.1 bln

UPDATE 3-GSK slides after buying cancer firm Tesaro for hefty $5.1 bln


GlaxoSmithKline has agreed to buy U.S. cancer specialist Tesaro for $5.1 billion, a costly investment to rebuild the pharmaceuticals business by new Chief Executive Emma Walmsley that unnerved investors. FILE PHOTO: The GlaxoSmithKline logo on top of GSK Asia House is seen through vertical louvres in Singapore, March 21, 2018.



from Biotech News
Share:

8@eight: ASX set for pull-back, focus on RBA

8@eight: ASX set for pull-back, focus on RBA


Australian shares are poised to drop at the open as an initial burst of enthusiasm over the US/China trade truce was questioned. ASX futures were 15 points lower at about 7.30am AEDT.



from Biotech News
Share:

Pharma giant GSK just made a $5.1 billion bet on a cancer drugmaker

Pharma giant GSK just made a $5.1 billion bet on a cancer drugmaker


GlaxoSmithKline just agreed to acquire the cancer drugmaker Tesaro for $5.1 billion in a bid to bulk up its cancer pipeline. GSK has been working to refresh its research-and-development strategy - in July it made a $300 million investment in the consumer-genetics company 23andMe.



from Biotech News
Share:

GlaxoSmithKline to spend $5.1B on cancer drugmaker Tesaro

GlaxoSmithKline to spend $5.1B on cancer drugmaker Tesaro


Shares of Tesaro soared early Monday after GlaxoSmithKline said it would pay about $5.1 billion in cash to buy the cancer drugmaker. Glaxo plans to pay $75 per share for Tesaro, which makes the ovarian cancer treatment Zejula.



from Biotech News
Share:

Unilever buys GSK's Indian Horlicks business for A 3.3 billion

Unilever buys GSK's Indian Horlicks business for A 3.3 billion


Unilever is to acquire Horlicks and a clutch of other health drink brands in India from drugs maker Glaxosmithkline for A 3.3 billion. Unilever is to acquire Horlicks and a clutch of other health drink brands in India from drugs maker Glaxosmithkline for A 3.3 billion.



from Biotech News
Share:

Rory Moore and GroGuru

Rory Moore and GroGuru


For the past decade, the bustling offices of EvoNexus have been the unofficial hub of the city's startup scene. When new entrepreneurs arrive in San Diego looking to get plugged in, they're often directed to Evo for its cachet and its network.



from Biotech News
Share:

Kite Announces Two-Year Data for Yescarta (Axicabtagene Ciloleucel)...

Kite Announces Two-Year Data for Yescarta (Axicabtagene Ciloleucel)...


Dec 2, 2018--Kite, a Gilead Company , announced two-year efficacy and safety data from the pivotal ZUMA-1 trial of Yescarta A in patients with refractory large B-cell lymphoma. With a minimum follow-up of two years after a single infusion of Yescarta , 39 percent of patients were in an ongoing response.



from Biotech News
Share:

Shingles shot in short supply

Shingles shot in short supply


If you're older than 50 and you've ever had the chickenpox, the good news is that the latest vaccine against shingles is very effective. Shortages of pharmaceuticals and medical equipment have become an increasing symptom of the U.S. medical system.



from Biotech News
Share:

Merck verkauft erfolgreich Consumer Health

Merck verkauft erfolgreich Consumer Health


Merck hat den Verkauf seines Consumer-Health-Geschäfts an Procter & Gamble (P&G) nach enger Abstimmung mit den Arbeitnehmervertretern, der Zustimmung aller relevanter Aufsichtsbehörden, sowie der Erfüllung weiterer üblicher Vollzugsbedingungen, erfolgreich abgeschlossen. Der erfolgreiche Vollzug der...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Bayer-Chef: Mehrzahl der Stellen wird nicht in Deutschland abgebaut

Bayer-Chef: Mehrzahl der Stellen wird nicht in Deutschland abgebaut


(dpa) Bayer will bei seinem angekündigten Stellenabbau die Mehrzahl der Jobs nicht in Deutschland streichen. «Es wird einen bedeutenden Anteil an Arbeitsplätzen in Deutschland betreffen, aber nicht die Mehrzahl der 12.000 Stellen, wie schon gemutmaßt wurde», sagte Bayer-Chef Werner Baumann der «Fran...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Reviewing CTI Industries

Reviewing CTI Industries


CTI Industries and Carlisle Companies are both industrial products companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, valuation, dividends and profitability. 4.8% of CTI Industries shares are owned by institutional investors.



from Biotech News
Share:

тарифный план Google Drive будет изменен на Google One

Тарифный план Google Drive будет изменен на Google One

Друзья, хорошие новости! Если у Вас оформлена платная подписка на хранилище Google Диска, то скоро Вы автоматически перейдете на Google One. Это наше новое предложение, позволяющее получить доступ к дополнительному пространству и преимуществам от Google.

100 ГБ
Вам по-прежнему будет доступно хранилище объемом 100 ГБ, предназначенное для файлов с Google Диска, из Gmail и Google Фото. Цена останется прежней, при этом Вы получите некоторые дополнительные преимущества.
Phone Logo Family Logo Star Logo
Используя Google One, Вы можете обращаться к специалистам за помощью в использовании продуктов и сервисов Google, добавить в тарифный план до 5 членов семьи и получать специальные бонусы.


Вам не нужно ничего делать. В ближайшие несколько недель мы пришлем письмо с подтверждением перехода на новый тарифный план и информацией о возможностях Google One. После этого плата будет взиматься за тарифный план Google One, а не Google Диска.
Чтобы получить дополнительную информацию,
посетите Справочный центр Google One.


from Мобильный Путешественник https://ift.tt/2PfG89V
via Video Collection
Share:

Kepos Capital LP Acquires 851 Shares of IDEXX Laboratories, Inc.

Kepos Capital LP Acquires 851 Shares of IDEXX Laboratories, Inc.


Kepos Capital LP lifted its holdings in shares of IDEXX Laboratories, Inc. by 5.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 17,808 shares of the company's stock after purchasing an additional 851 shares during the period.



from Biotech News
Share:

Bridgewater Associates LP Buys 8,401 Shares of United Therapeutics Co.

Bridgewater Associates LP Buys 8,401 Shares of United Therapeutics Co.


Bridgewater Associates LP lifted its stake in United Therapeutics Co. by 18.5% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission.



from Biotech News
Share:

For Your Health: Flu season is here - fight it by getting vaccinated

For Your Health: Flu season is here - fight it by getting vaccinated


Fall is the season when the spirit of giving starts coming into full gear. Unfortunately, fall is also when people may begin to give each other an unwanted gift - the seasonal flu.



from Biotech News
Share:

Merck KGaA (MKGAF) Receiving Positive Media Coverage, InfoTrie Reports

Merck KGaA (MKGAF) Receiving Positive Media Coverage, InfoTrie Reports


News stories about Merck KGaA have trended positive on Saturday, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive media coverage by reviewing more than 6,000 news and blog sources in real time.



from Biotech News
Share:

Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 BELIEVE Trial Evaluating Luspatercept in Adult Patients with Beta-Thalassemia at ASH 2018

Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 BELIEVE Trial Evaluating Luspatercept in Adult Patients with Beta-Thalassemia at ASH 2018


SUMMIT, N.J. & CAMBRIDGE, Mass.-- --Dec 1, 2018--Celgene Corporation and Acceleron Pharma Inc. today announced results from a pivotal, phase 3 trial evaluating the safety and efficacy of luspatercept for the treatment of adults with beta-thalassemia-associated anemia who require regular red blood cell transfusions. The data were presented by Maria Domenica Cappellini, M.D. in an oral session of the 60 th American Society of Hematology Annual Meeting and Exposition in San Diego, CA .



from Biotech News
Share:

Tower Research Capital LLC TRC Acquires 206,337 Shares of Pfizer Inc.

Tower Research Capital LLC TRC Acquires 206,337 Shares of Pfizer Inc.


Tower Research Capital LLC TRC raised its holdings in Pfizer Inc. by 25,792.1% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 207,137 shares of the biopharmaceutical company's stock after acquiring an additional 206,337 shares during the quarter.



from Biotech News
Share:

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings


All TEGNA stations will return to the DISH lineup effective immediately. )--Magenta Therapeutics , a clinical-stage biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to mo... )--On Monday, December 3, 2018, the NYSE will observe a one-minute moment of silence at 9:20 a.m. Eastern Time in honor of President George H.W. Bush.



from Biotech News
Share:

Huber | Martinswerk Increases Aluminum Oxides, Fire Retardant Additives Prices

Huber | Martinswerk Increases Aluminum Oxides, Fire Retardant Additives Prices


Martinswerk, part of the Huber Engineered Materials division of J.M. Huber Corporation, announced a global price increase of up to 15 percent depending on product grade and packaging for its Martoxid and Compalox aluminum oxides, Martinal and Hydral fine precipitated hydrates and all other alumina trihydrate grades. European price increases take effect Dec. 1, 2018, and Jan. 1, 2019, in North America and the Asia Pacific.



from Biotech News
Share:

Drug Overdose Deaths In The U.S. Hit Record High [Infographic]

Drug Overdose Deaths In The U.S. Hit Record High [Infographic]


Between 2016 and 2017, the overall rate of overdose deaths increased 9.6% while the death rate from synthetic opioids such as fentanyl grew by a shocking 45%. In 1999, the age-adjusted rate of drug overdose deaths in the U.S. was 6.1 per 100,000 people and that soared to 21.7 in 2017.



from Biotech News
Share:

How Dr Khaldi went from maths academic to biotech trailblazer

How Dr Khaldi went from maths academic to biotech trailblazer


Food science: Dr Nora Khaldi founded Nuritas, which uses big data techniques to discover peptides for use in new drugs. Photo: Fred McGregor Her company, Nuritas, became the first Irish biotech company backed by the European Investment Bank when it made a a 30m loan to the Dublin-based entity.



from Biotech News
Share:

Recent Analysts' Ratings Changes for Vanda Pharmaceuticals

Recent Analysts' Ratings Changes for Vanda Pharmaceuticals


11/17/2018 - Vanda Pharmaceuticals was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $26.00 price target on the stock.



from Biotech News
Share:

-$0.31 Earnings Per Share Expected for Novan Inc (NOVN) This Quarter

-$0.31 Earnings Per Share Expected for Novan Inc (NOVN) This Quarter


Wall Street analysts expect Novan Inc to announce earnings per share of for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Novan's earnings.



from Biotech News
Share:

CDC Once Again Completely Ignores Safer Sex Promotion in World AIDS Day Message, Says AHF

CDC Once Again Completely Ignores Safer Sex Promotion in World AIDS Day Message, Says AHF


Nov 30, 2018-- AIDS Healthcare Foundation today once again sharply criticized the Centers for Disease Control and Prevention after it issued a World AIDS Day message promoting HIV prevention and treatment in an email to colleagues in the community under the subject line: " ." The 400+ word letter/update on HIV/AIDS and prevention in the U.S. failed to make any mention of safer sex or condom use.



from Biotech News
Share:

Fortress Biotech (FBIO) CFO Robyn Hunter Sells 20,370 Shares

Fortress Biotech (FBIO) CFO Robyn Hunter Sells 20,370 Shares


Fortress Biotech CFO Robyn Hunter sold 20,370 shares of the company's stock in a transaction dated Friday, November 23rd. The shares were sold at an average price of $1.29, for a total transaction of $26,277.30.



from Biotech News
Share:

FDA approves Meridian Bioscience's test for herpes in newborns

FDA approves Meridian Bioscience's test for herpes in newborns


REUTERS: The U.S. Food and Drug Administration approved on Friday the first test: a diagnostic from Meridian Bioscience Inc: to help detect a type of herpes virus in newborns. Meridian's Alethia CMV Assay Test System detects cytomegalovirus DNA from saliva swabs and won approval for use in babies younger than 21 days of age infected during pregnancy.



from Biotech News
Share:

US Biotech Firms Made China's Gene-Edited Babies Possible

US Biotech Firms Made China's Gene-Edited Babies Possible


Combined with other changes that had sprung biology free from the ivory tower, the concern was that someone with a modicum of expertise would go rogue and start a Crispr-It-Yourself baby project. Only three years later, we now know that someone is named He Jiankui.



from Biotech News
Share:

Should PoMo Architecture, at the 50-Year Mark, Be Saved?

Should PoMo Architecture, at the 50-Year Mark, Be Saved?


Post-Modernist buildings, those teasing, colorful mash-ups of columns, pilasters and pediments, were both praised and reviled in the 1970s and '80s, their heyday. But by the end of the '80s they fell out of fashion, consigned with surprising abruptness to the dustbin of architectural history.



from Biotech News
Share:

Primecap Management Co. CA Has $987.71 Million Stake in Alkermes Plc

Primecap Management Co. CA Has $987.71 Million Stake in Alkermes Plc


Primecap Management Co. CA decreased its stake in shares of Alkermes Plc by 0.3% in the 3rd quarter, according to its most recent 13F filing with the SEC.



from Biotech News
Share:

Outside the Box: Chinese biotech stocks hit by a double whammy, which means it's time to buy

Outside the Box: Chinese biotech stocks hit by a double whammy, which means it's time to buy


Have investors hit peak negativity on China-based companies? I think there's a good chance they have. If so, it's time to buy China stocks, especially in biotechnology.



from Biotech News
Share:

Progenics Pharmaceuticals, Inc. (PGNX) Given Consensus Recommendation of "Buy" by Brokerages

Progenics Pharmaceuticals, Inc. (PGNX) Given Consensus Recommendation of "Buy" by Brokerages


Progenics Pharmaceuticals, Inc. has received an average recommendation of "Buy" from the six research firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company.



from Biotech News
Share:

Eli Lilly And Co (LLY) Given Average Recommendation of "Buy" by Brokerages

Eli Lilly And Co (LLY) Given Average Recommendation of "Buy" by Brokerages


Shares of Eli Lilly And Co have earned an average recommendation of "Buy" from the twenty-two brokerages that are presently covering the firm, Marketbeat Ratings reports. Nine equities research analysts have rated the stock with a hold recommendation and twelve have given a buy recommendation to the company.



from Biotech News
Share:

Finanzen: Modernisierungsmaßnahmen in der Mietwohnung : Mieterhöhung nach Modernisierung

Steht eine Sanierung der Wohnung an, müssen sich Mieter auf Lärm, Dreck und eine höhere Miete einstellen. Der Vermieter muss die Baumaßnahmen aber ankündigen und darf bloße Reparaturkosten nicht auf den Mieter umlegen.

from Finanztip Feed
Supported by Video Collection
Share:

La Jolla art gallery owner charged with trafficking ivory

La Jolla art gallery owner charged with trafficking ivory


The Carlton Gallery in La Jolla, its owner and an employee are facing criminal charges for allegedly trafficking $1.3 million in illegal ivory, San Diego City Attorney Mara Elliott announced Wednesday. Elliott's office has been investigating the Carlton Gallery since May 2017 and performed a sting operation on the business on May 1 of this year, with the help of wildlife officers from the state Department of Fish and Wildlife.



from Biotech News
Share:

Finanzen: Mietpreisbremse : Mietpreisbremse

In über 300 Städten müssen sich Vermieter bei einer Neuvermietung an die Mietpreisbremse halten. Mieter sollten ihre Rechte kennen und nicht jeden Mietpreis akzeptieren.

from Finanztip Feed
Supported by Video Collection
Share:

a 30m for Dublin biotech firm founded by Trinity graduate

a 30m for Dublin biotech firm founded by Trinity graduate


A groundbreaking Dublin biotech firm, backed in part by Bono and The Edge, has won a 30m in financing from the European Investment Bank in its first direct financing for an Irish firm in the sector. A groundbreaking Dublin biotech firm, backed in part by Bono and The Edge, has won a 30m in financing from the European Investment Bank in its first direct financing for an Irish firm in the sector.



from Biotech News
Share:

Сезон 2018-2019: цены на скипассы в Гудаури

Горнолыжный курорт Гудаури

Гудаури - молодой развивающийся горнолыжный курорт, находится в Казбегском районе Грузии в 120 км от Тбилиси на высоте 2196 м, вблизи Крестового перевала. Координаты курорта 42°27'39" с.ш., 44°28'59" в.д. (парковка у отеля Марко Поло, WGS84). Самой главной достопримечательностью Гудаури является фрирайд - спуск по целинным полям. Глубокий снежный покров, отсутствие камней, лавинной опасности делают Гудари Меккой фрирайда. Также вокруг курорта огромное количество внетрассовых спусков для беккантри и хели-ски. 

Горнолыжный курорт Гудаури - Карта Горнолыжных Трасс


О Снеге:  Горнолыжный сезон в Гудаури продолжается с второй половины декабря по май, в это время возможно комфортное катание на всех трассах. В снежные годы в ноябре и мае возможно катание на третьей, пятой очереди.
В сезоне 2014-15 была успешно запущена система искусственного  оснежнения трассы первой очереди. 

Когда начало катания зимнего сезона 2018-2019 в Гудаури?

- Снег выпал 12 ноября (ссылка). Откроется ли курорт раньше официальной даты открытия?-Может ответить только небесная канцелярия, а мы будем надеяться. Сезоны 2016-2017-18 открыты 10 декабря, раньше планируемого срока, из-за очень большого количества снега ...тьфутьфу Сезоны 2014-15-16 были очень снежными.  До 2014-15 несколько лет отмечалась снежная аномалия: Сезон 2013-14: официально открыт 25 января, но канатки работали с конца декабря и снег для катания был на самом верху. Сезон 2011-2012: на НГ снег для катания на третьей очереди был, по мнению старожилов, но администрация курорта включила канатки 10 января. Сезон 2010-2011, снег в Гудаури появился 26 января.  



Трассы и подъемники в Гудаури

Нижняя станция подъемника находится на высоте 1990м, а верхняя на 3307м. Подъемники Doppelmayer, Poma. Протяженность трасс 50 км. Общее число трасс 22. Подъемники курорта могут одновременно обслуживать 11000 людей. 218 гектар трасс каждую ночь обрабатываются ратраками. 20% трасс для профессионалов 80% - для любителей.  На первой трассе установлены снежные пушки.

Первая : "Пирвели" 1992-2065м- 3 кресла (со снежными пушками и вечером освещена),
вторая: "Солико" 2157-2709м- 3 кресла,
третья: "Кудеби" 2703-3006м - 3 кресла, (на вершину Кудеби)
"Сноу Парк"- 3 кресла, 2720-2846м
=  "Садзеле"- 4 кресла, 2795-3276м, (на соседнюю вершину Садзеле).
гондольная канатная дорога "Гудаура" - 2724-2777м, 10 человек,
"Шино"-, 6 кресел, 2186-2724
учебный склон "Зума" с бугельным подъемником POMA- 2151-2210м 
Альпина: 2300-2320м
Бомбора: 2740-2780
Baby
Цены на подъемники на Горнолыжном Курорте Гудаури в Грузии
  • Сноу-парк для экстримального катания 
  • Тюбинговая трасса и бегущая дорожка (SunKid people mover) - 300м. Бесплатны для посетителей курорта.


    Расписание работы подъемников в Гудаури, Грузия

    Подъемники работают независимо от количества катающихся, на данной очереди. Закрываются они лишь по погодным условиям, при очень плохой видимости или сильном ветре. На случай отключения электричества канатные дороги оборудованы аварийными дизелями.
    • Зимой: с 10 до 17 часов. 
    • Март 2018 9:00 -16:00. Весной (апрель, конец марта): пн.-пятн.: 9:00 -15:00 суб. воскр.: 9:00 -16:00.  
    • Цены Лета 2019: Одна поездка – 5 Gel Садзеле (Gudaura, Snow Park, Sadzele) – 15 Gel Велосипедный проездной на 1 день – 12 Gel Проездной на все лето– 60 Gel 20% скидка для групп 10-20 человек, 30% для групп от 20 человек. Велотрасса скоростного спуска длиной 4790м.
    Вечернее катание на первой трассе по субботам 20:00 -22:00.

    Подготовлено по материалам сайта: Гудаури.инфо


from Мобильный Путешественник https://ift.tt/2DTcDZh
via Video Collection
Share:

Pharmacy News Digest

Архив блога